Related Experiment Video
Updated: Jul 5, 2025

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Natural Flavonoid Apigenin, an Effective Agent Against Nervous System Cancers
Mohammad-Sadegh Lotfi1, Fatemeh B Rassouli2
1Novel Diagnostics and Therapeutics Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
Abstract:
Cancer is a serious public health concern worldwide, and nervous system (NS) cancers are among the most life-threatening malignancies. Efforts have been devoted to introduce natural anticancer agents with minimal side effects. Apigenin is an edible flavonoid that is abundantly found in many vegetables and fruits. Various pharmaceutical activities, including anti-inflammatory, antioxidative, antimicrobial, and anticancer effects have been reported for apigenin. This review provides insights into the therapeutic effects of apigenin and flavonoids with similar structure on glioblastoma and neuroblastoma. Current evidence indicates that apigenin has the unique ability to cross the blood-brain barrier, and its antioxidative, anti-inflammatory, neurogenic, and neuroprotective effects have made this flavonoid a great option for the treatment of neurodegenerative disorders. Meanwhile, apigenin has low toxicity on normal neuronal cells, while induces cytotoxicity on NS cancer cells via triggering several signal pathways and molecular targets. Anticancer effects of apigenin have been contributed to various mechanisms such as induction of cell cycle arrest and apoptosis, and inhibition of migration, invasion, and angiogenesis. Although apigenin is a promising pharmaceutical agent, its low bioavailability is an important issue that must be solved before introducing to clinic. Recently, nano-delivery of apigenin by liposomes and poly lactic-co-glycolide nanoparticles has greatly improved functionality of this agent. Hence, investigating pharmaceutical effects of apigenin-loaded nanocarriers on NS cancer cell lines and animal models is recommended for future studies.
Insights
Apigenin, a natural flavonoid, shows promise in treating nervous system cancers like glioblastoma and neuroblastoma. Nano-delivery systems enhance its effectiveness, making it a potential therapeutic agent with low toxicity to normal cells.
Area of Science:
- Oncology
- Neuroscience
- Pharmacology
Background:
- Nervous system (NS) cancers are life-threatening malignancies with limited treatment options.
- Natural compounds are being explored for anticancer therapies with fewer side effects.
- Apigenin, an edible flavonoid, exhibits diverse pharmacological activities, including anticancer effects.
Purpose of the Study:
- To review the therapeutic potential of apigenin and related flavonoids against glioblastoma and neuroblastoma.
- To explore apigenin's mechanisms of action and its ability to cross the blood-brain barrier.
- To assess the impact of nano-delivery systems on apigenin's efficacy for NS cancers.
Main Methods:
- Literature review of studies on apigenin and its effects on NS cancer cell lines and animal models.
- Analysis of apigenin's molecular targets and signaling pathways involved in cytotoxicity.
- Evaluation of research on nano-delivery systems for apigenin, such as liposomes and nanoparticles.
Main Results:
- Apigenin demonstrates anticancer effects by inducing cell cycle arrest, apoptosis, and inhibiting migration, invasion, and angiogenesis.
- Apigenin possesses antioxidative, anti-inflammatory, neurogenic, and neuroprotective properties, with low toxicity to normal neuronal cells.
- Nano-delivery significantly enhances apigenin's bioavailability and therapeutic functionality.
Conclusions:
- Apigenin is a promising agent for treating NS cancers due to its unique properties and low toxicity.
- Overcoming apigenin's low bioavailability through nano-delivery is crucial for clinical application.
- Further research on apigenin-loaded nanocarriers in NS cancer models is recommended.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...